Prucalopride
SIGMA/SML1371 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 179474-81-8
Empirical Formula (Hill Notation): C18H26ClN3O3
Molecular Weight: 367.87
Linear Formula: C18H26ClN3O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H26ClN3O3/c1-24-9-2 |
| InChI key | ZPMNHBXQOOVQJL-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | COCCCN1CCC(NC(C2=CC(Cl)=C |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | In healthy male individuals, prucalopride decreases the display of esophageal acid and promotes gastric emptying. It is effective, safe and shows good tolerance for the treatment of men with chronic constipation. |
| Biochem/physiol Actions: | Prucalopride is a selective 5-HT4 serotonin receptor agonist with enterokinetic activity. |
| Biochem/physiol Actions: | Prucalopride is a selective 5-HT4 serotonin receptor agonist with enterokinetic activity. 5-HT4 receptors are GPCRs that are expressed in the CNS and peripheral tissues. The receptor has a role in GI motility disorders such as irritable bowel syndrome and idiopathic constipation. Agonists are prokinetic and of potential use for disoroders of reduced motility. Prucalopride is a selective 5-HT4 serotonin receptor agonist with enterokinetic activities. Prucalopride has pK(i) values of 8.60 and 8.10 for the human 5-HT(4a) and 5-HT(4b) receptor, respectively, and at least 290-fold selectivity for 5-HT4 over other serotonin and dopamine receptors. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 - H400 |
| Precautionary statements | P273 - P302 + P352 - P305 + P351 + P338 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



